“CTD module 3 – Quality (EU). Active Pharmaceutical Ingredient (API) / Drug Substance in medicinal products for Human use” has been added to your cart. View cart
Regulatory framework in Poland with key local legislations
MAH requirements based on the Pharmaceutical Act, such as notification of initial placing into the market, shortage notification (temporary/permanent), „sunset clause”, annual fees
Local regulatory requirements in line with various Regulations: MAA, variations, how to handle formal requirements in Poland, grouping „in consultations”, preparing mock ups and possibilites of MA withdrawal
The Office for Registration of Medicinal Products for human use: structure, activities and quality policy